C12Y 108/04008
Phosphoadenylyl-sulfate reductase
Official title: Phosphoadenylyl-sulfate reductase (thioredoxin) (1.8.4.8)
C12Y108/04008 (Phosphoadenylyl-sulfate reductase) appears on 2 US grants and 6 published applications in this corpus.
Search patents in C12Y- Granted patents
- 2
- Published applications
- 6
- Assignees
- 5
- Inventors
- 20
- Latest grant
- 14 Apr 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2016 | 0 | 1 |
| 2017 | 0 | 0 |
| 2018 | 0 | 1 |
| 2019 | 0 | 0 |
| 2020 | 1 | 0 |
| 2021 | 0 | 0 |
| 2022 | 0 | 3 |
| 2023 | 0 | 1 |
| 2024 | 0 | 0 |
| 2025 | 0 | 0 |
| 2026 | 1 | 0 |
By publication year. 2026 runs to 8 Oct.
Recent patents
- Biocatalyst as a core component of an enzyme-catalyzed redox system for the biocatalytic reduction of cystine20 Apr 2023US 2023/0124898 A1Wacker Chemie AG
- Recombinant microorganisms for in vivo production of sulfated glycosaminoglycans20 Oct 2022US 2022/0333144 A1Rensselaer Polytechnic Institute
- Engineered biosynthetic pathways for production of cystathionine by fermentation6 Oct 2022US 2022/0315965 A1Zymergen Inc.
- Engineered biosynthetic pathways for production of l-homocysteine by fermentation26 May 2022US 2022/0162655 A1Zymergen Inc.
- Thioredoxin, thioredoxin peptides or derivatives for treatment of age-related hypertension9 Aug 2018US 2018/0221454 A1Board of Regents, The University of Texas System
Most cited
By later US patents